Newsletter

Powell, Elizabeth A.

View as
Sort by
Display per page

A Note on Management Communication: Module Four

This note is an introduction to the first-year course Management Communication: Module Four. See also "A Note on Management Communication: Module One" (UVA-BC-0168), "A Note on Management Communication: Module Two" (UVA-BC-0169), and "A Note on Management Communication: Module Three" (UVA-BC-0170). ...

A Note on Management Communication: Module One

This note is an introduction to the first-year course Management Communication Module One. See also "A Note on Management Communication Module Two" (UVA-BC-0169). ...

A Note on Management Communication: Module Three

This note is an introduction to the first-year course Management Communication: Module Three. See also "A Note on Management Communication: Module One" (UVA-BC-0168), "A Note on Management Communication: Module Two" (UVA-BC-0169), and "A Note on Management Communication: Module Four" (UVA-BC-0171). ...

A Note on Management Communication: Module Two

This note is an introduction to the first-year course Management Communication: Module Two. See also "A Note on Management Communication: Module One" (UVA-BC-0168). ...

Abiomed and the AbioCor Clinical Trials (A)

To protect patient confidentiality, Abiomed, makers of the AbioCor artificial heart, adopt a 30-day "quiet period" surrounding implantations, which is construed by mainstream media as a "news blackout." In late 2002, James Quinn, the fifth transplant recipient, dies after 289 days. A month later, in a New York Times article describing Quinn's pain and suffering, Quinn's widow claims that her husba ...

Abiomed and the AbioCor Clinical Trials (B)

In late 2002, a sensational article in the New York Times depicting James Quinn's experience and death following implantation with the AbioCor artificial heart raises questions about Abiomed's handling of the informed consent process related to its clinical trials. At the same time, investor confidence in the company wanes due to the apparent stall in the clinical trial's progress. This B case ill ...

Euronext N.V.: The Fight for LIFFE (A)

Euronext N.V. has a battle on its hands as it seeks to gain scale and scope if it is to survive industry consolidation. A seemingly perfect acquisition opportunity has presented itself, and Euronext will have to persuade the London International Financial Futures and Options Exchange to choose its bid, ahead of bids from bigger and better-known rivals in London and Frankfurt. This case focuses on ...

Euronext N.V.: The Fight for LIFFE (B)

The bidding begins and ends in this case, which is the sequel to Euronext N.V.: The Fight for LIFFE (A). ...

Euronext N.V.: The Fight for LIFFE (C)

This C case in the "Euronext N.V." series is an interview with the CEO of LIFFE in which he explains why LIFFE picked Euronext as the winner of the auction. ...

How Normal is Normal? The Mitsubishi Motors Sexual Harassment Case

This case illustrates Mitsubishi Motors Manufacturing of America's (MMMA) responses to allegations of sexual harassment in 1996 at its Normal, Illinois, facility. The majority of the case focuses on major events that took place between 1992 and spring 1996, culminating in an Equal Employment Opportunity Commission (EEOC) investigation and class-action suit, which at the time was estimated to be th ...

Leadership Presence and the Courage to Speak

This note applies the concept of "leadership presence" as established by Belle Linda Halpern and Kathy Lubar to the concerns of business leaders. ...

Mall of America

The Mall of America's public relations manager considers whether to institute an escort policy aimed at curbing the disruptive behavior of some teenagers who frequent the Mall. Support for the policy is mixed. Mall visitors and merchants are generally in favor of the policy, while teens, some community residents, and activists argue that it is too extreme. To make a decision, mall officials must e ...
Stay Connected: